<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Introduction to Preclinical Immuno-Oncology In Vivo Models

Immuno-oncology research has dramatically increased over the past few years, due to the clinical and commercial success of novel immunotherapies such as checkpoint inhibitors.